Acute Otitis Media: Next Step When Second-Line Antibiotic Therapy Has Not Resolved Symptoms (No Penicillin Allergy)

This protocol targets patients with acute otitis media and associated acute myringitis who are not allergic to penicillin and whose infection has persisted despite escalation to a second-line antibiotic regimen.

Clinical Scenario

The patient has acute otitis media without penicillin allergy. In this population, high-dose amoxicillin is the established antibiotic of choice for initial management. When first-line therapy is insufficient, escalation to a second-line agent is the next indicated step.

Previous Treatment Failure

This protocol applies when a second-line agent — high-dose amoxicillin-clavulanate or ceftriaxone — has failed to achieve its intended goals: resolution of AOM symptoms and of tympanic membrane bulging or inflammation. When those targets remain unmet, further escalation is required.

Next-Step Approach

When second-line therapy has not resolved the infection, this protocol calls for a combination antibiotic strategy, with procedural intervention as an alternative option. Specialist consultation is also among the considerations. The complete regimen — including agent selection, sequencing, and criteria for each option — is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

High-dose amoxicillin (80 to 90 mg per kg per day) is the antibiotic of choice for treating acute otitis media in patients who are not allergic to penicillin.

High-dose amoxicillin should be the initial treatment in the absence of a known allergy.

If symptoms persist despite appropriate antibiotic therapy, consider intramuscular ceftriaxone (Rocephin), clindamycin, or tympanocentesis.

Clindamycin (30-40 mg/kg per day in 3 divided doses) plus third-generation cephalosporin

Tympanocentesis†

Consult specialist†

View source ↗